Skip to main content
. 2020 Aug 9;105(11):e3971–e3980. doi: 10.1210/clinem/dgaa506

Table 1.

Patient and nodule characteristics by surgery status

Characteristic No Surgery (n = 251) Surgery (n = 38) P Valuea
Age at biopsy, mean (SD) 55.8 (13.6) 49.5 (15.0) 0.02
Gender, female (%) 192 (76.5) 29 (76.3) 0.91
Bethesda category (%) 0.99
 III 187 (74.5) 28 (73.7)
 IV 64 (25.5) 10 (26.3)
Hürthle cell changes (%) 29 (11.6) 5 (13.2) 0.11
Race (%) 0.99
 Caucasian 209 (83.3) 33 (86.8)
 African American 32 (12.7) 5 (13.2)
 Asian 8 (3.2) 0 (0)
 Hispanic 1 (0.4) 0 (0)
 Unknown 1 (0.4) 0 (0)
ATA sonographic risk (%) 0.69
 High 14 (5.6) 3 (7.9)
 Intermediate 95 (37.8) 12 (31.6)
 Low 122 (48.6) 22 (57.9)
 Very low 12 (4.8) 1 (2.6)
 Unknown 8 (3.2) 0 (0)
TIRAD risk (%) 0.87
 5 12 (4.8) 3 (7.9)
 4 99 (39.4) 16 (42.1)
 3 108 (43.0) 15 (39.5)
 2 18 (7.2) 3 (7.9)
 1 6 (2.4) 1 (2.6)
 Unknown 8 (3.2) 0 (0)
Multinodular (%) 171 (68.1) 30 (78.9) 0.16
Presence of Afirma suspicious nodule outside the index nodule (%) 4 (1.6) 7 (18.4) <0.001
Compressive symptoms (%) 17 (6.8) 15 (39.5) <0.001
Initial maximum nodule size (cm), median (IQR) 2.0 (1.5, 2.8) 2.8 (1.8, 3.6) <0.001
Initial nodule volume (cm3), median (IQR) 1.8 (0.8, 4.1), n = 244 4.5 (1.4, 10.1) <0.001
Last follow-up maximum nodule size (cm), median (IQR) 2.0 (1.5, 2.8), n = 149 3.4 (2.7, 3.7), n = 18 0.001
Last follow-up nodule volume (cm3), median (IQR) 2.0 (0.9, 4.6), n = 149 6.9 (3.7, 14.2), n = 18 0.02
Change in nodule size at last follow-up (cm), median (IQR) 0.0 (–0.2, 0.2), n = 149 0.3 (0.0, 0.5), n = 18 0.17
Change in nodule volume at last follow-up (cm3), median (IQR) 0.1 (–0.4, 0.9), n = 143 0.5 (0.0, 4.4), n = 18 0.06

Abbreviations: ATA, American Thyroid Association; IQR, interquartile range; SD, standard deviation; TIRAD, Thyroid Imaging Reporting and Data Systems.

aUnivariable Cox proportional hazards model, excludes missing/unknown values.